United States · FDA National Drug Code directory

Gabapentin

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
71610-044_a695e055-6531-4b51-969f-62165d703511
Product NDC
71610-044
Form
TABLET, FILM COATED
Composition / generic term
GABAPENTIN
Labeler
Aphena Pharma Solutions - Tennessee, LLC
Marketing category
ANDA
Marketing start / end (source format)
20140111
Source listing expiry
20261231

Source-listed ingredients

  • GABAPENTIN — 600 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 30 TABLET, FILM COATED in 1 BOTTLE (71610-044-30) · 71610-044-30
  • 45 TABLET, FILM COATED in 1 BOTTLE (71610-044-45) · 71610-044-45
  • 60 TABLET, FILM COATED in 1 BOTTLE (71610-044-53) · 71610-044-53
  • 90 TABLET, FILM COATED in 1 BOTTLE (71610-044-60) · 71610-044-60
  • 120 TABLET, FILM COATED in 1 BOTTLE (71610-044-70) · 71610-044-70
  • 135 TABLET, FILM COATED in 1 BOTTLE (71610-044-73) · 71610-044-73
  • 180 TABLET, FILM COATED in 1 BOTTLE (71610-044-80) · 71610-044-80
  • 270 TABLET, FILM COATED in 1 BOTTLE (71610-044-92) · 71610-044-92

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →